InspireMD (NSPR) Income from Continuing Operations (2010 - 2025)
InspireMD's (NSPR) quarterly Income from Continuing Operations came in at 75652000.0 in Q4 2025, down 30.89% year-on-year from 109470197.89 in Q4 2024, and down 479.66% quarter-over-quarter from 13051000.0 in Q3 2025.
InspireMD (NSPR) Income from Continuing Operations (2010 - 2025) Analysis & Trends
InspireMD's Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 75652000.0 for Q4 2025.
- On a quarterly basis, Income from Continuing Operations fell 30.89% year-over-year to 75652000.0 in Q4 2025; TTM through Dec 2025 was 113182000.0, a 38.14% decrease from a year earlier, with the FY2025 full-year figure at 49894000.0, down 97.7% from the prior year.
- Income from Continuing Operations declined to 75652000.0 in Q4 2025 per NSPR's latest filing, from 13051000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 3243000.0 in Q1 2021 and bottomed at 75652000.0 in Q4 2025.
- The 5-year median for Income from Continuing Operations is 5479000.0 (2023), against an average of 13036550.0.
- Across the five-year window, Income from Continuing Operations jumped 89.57% in 2021 and slumped 251.69% in 2023, its largest moves.
- Year by year, Income from Continuing Operations stood at 4052000.0 in 2021, then fell by 18.88% to 4817000.0 in 2022, then slumped by 251.69% to 16941000.0 in 2023, then tumbled by 241.17% to 57797000.0 in 2024, then plunged by 30.89% to 75652000.0 in 2025.
- Per Business Quant, the three latest NSPR Income from Continuing Operations figures stand at 75652000.0 (Q4 2025), 13051000.0 (Q3 2025), and 13019000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn | -75.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -75.65 Mn |
| Sep 30, 2025 | -13.05 Mn |
| Jun 30, 2025 | -13.02 Mn |
| Mar 31, 2025 | -11.46 Mn |
| Dec 31, 2024 | -57.80 Mn |
| Sep 30, 2024 | -8.46 Mn |
| Jun 30, 2024 | -8.26 Mn |
| Mar 31, 2024 | -7.41 Mn |
| Dec 31, 2023 | -16.94 Mn |
| Sep 30, 2023 | -5.64 Mn |
| Jun 30, 2023 | -5.32 Mn |
| Mar 31, 2023 | -4.38 Mn |
| Dec 31, 2022 | -4.82 Mn |
| Sep 30, 2022 | -4.53 Mn |
| Jun 30, 2022 | -4.64 Mn |
| Mar 31, 2022 | -4.48 Mn |
| Dec 31, 2021 | -4.05 Mn |
| Sep 30, 2021 | -4.07 Mn |
| Jun 30, 2021 | -3.51 Mn |
| Mar 31, 2021 | -3.24 Mn |